Interplay of m6A RNA methylation and gut microbiota in modulating gut injury
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Feb. 17, 2025
The
gut
microbiota
undergoes
continuous
variations
among
individuals
and
across
their
lifespan,
shaped
by
diverse
factors
encompassing
diet,
age,
lifestyle
choices,
medication
intake,
disease
states.
These
microbial
inhabitants
play
a
pivotal
role
in
orchestrating
physiological
metabolic
pathways
through
the
production
of
metabolites
like
bile
acids,
choline,
short-chain
fatty
neurotransmitters,
thereby
establishing
dynamic
"gut-organ
axis"
with
host.
intricate
interplay
between
host
is
indispensable
for
health,
RNA
N6-methyladenosine
modification,
epigenetic
mark
on
RNA,
emerges
as
key
player
this
process.
M6A
most
prevalent
internal
modification
eukaryotic
has
garnered
significant
attention
realm
epigenetics.
Recent
findings
underscore
its
potential
to
influence
diversity
intestinal
barrier
function
modulating
gene
expression
patterns.
Conversely,
microbiota,
impact
landscape
cells,
may
indirectly
regulate
recruitment
activity
m6A-modifying
enzymes.
This
review
endeavors
delve
into
biological
functions
m6A
consequences
injury
pathogenesis,
elucidating
partial
possible
mechanisms
which
maintain
health
homeostasis.
Furthermore,
it
also
explores
crosstalk
them
injury,
offering
novel
perspective
that
deepens
our
understanding
underlying
diseases.
Language: Английский
Ficus pumila fruit polysaccharide alleviates OVA-induced allergic asthma mice through the MAPK/NF-κB signaling pathway
Xiaomei Ye,
No information about this author
Shiru Mo,
No information about this author
Chengyuan Wang
No information about this author
et al.
Food Bioscience,
Journal Year:
2025,
Volume and Issue:
unknown, P. 105827 - 105827
Published: Jan. 1, 2025
Language: Английский
Airway Microbiota Profiles in Children With and Without Asthma: A Comparative Study
Journal of Asthma and Allergy,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 349 - 361
Published: March 1, 2025
Asthma
is
a
common
chronic
respiratory
disease
that
affects
children
and
adults
can
have
serious
impact
on
their
quality
of
life.
Factors
contributing
to
the
development
asthma
related
exacerbations
are
multifactorial,
with
microbial
communities
colonizing
airways
possibly
playing
key
role.
The
study
included
asthmatic
(79)
healthy
(57)
aged
5-16
years.
Nasal
throat
swabs
were
collected,
bacterial
(16s
rRNA)
fungal
(18s
amplicon
sequence
analysis
was
performed.
Diversity
indices
most
abundant
genera
estimated
accordingly.
At
level
bacteriome
in
nasal
samples,
group
had
significantly
lower
diversity
than
control
(p
=
0.02).
However,
microbiota
cohort
more
evenly
distributed,
staphylococci
enriched
group.
Throat
samples
collected
from
revealed
<
0.0001),
significant
difference
species
composition
between
two
groups
0.005).
Enriched
different
within
subgroups
(controlled
vs
uncontrolled
asthma).
microbiome
showed
no
richness
groups,
however,
beta
(species
composition)
detected.
Malassezia
species,
while
cases
Mucor
species.
On
other
hand,
specimens
found
be
Candida
Saccharomyces.
Our
findings
suggest
less
diverse
certain
enriching
some
groups.
Addressing
biomarkers
influence
progression
could
lead
improved
care
for
suffering
severe
episodes,
by
including
targeted
therapies
prevention
strategies.
Language: Английский
PROBIÓTICOS NO TRATAMENTO DO MIELOMA MÚLTIPLO: UMA REVISÃO
Ana Savia Cardoso Brito,
No information about this author
Gildeanni Iasmim Alves Vieira,
No information about this author
Alessandra Souza dos Santos
No information about this author
et al.
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218,
Journal Year:
2024,
Volume and Issue:
5(6), P. e565340 - e565340
Published: June 7, 2024
O
mieloma
múltiplo
(MM)
é
a
segunda
neoplasia
hematológica
mais
comum,
caracterizada
pela
proliferação
descontrolada
de
células
plasmáticas,
resultando
em
complicações
como
anemia,
lesões
ósseas
e
insuficiência
renal.
Estudos
sugerem
que
microbiota
intestinal
pode
influenciar
progressão
do
MM
resposta
ao
tratamento.
Nesse
contexto,
os
probióticos,
conhecidos
por
seus
benefícios
à
saúde
intestinal,
apresentam
potencial
terapêutico
para
o
tratamento
MM,
melhorando
imunológica.
Dessa
forma,
objetivou-se
realizar
uma
revisão
sistemática
através
Methodi
Ordinatio
sobre
uso
probióticos
no
múltiplo.
As
buscas
foram
feitas
mês
abril
2024,
nas
bases
dados:
Embase,
Scopus
Web
of
Science.
Não
empregados
intervalos
temporais.
A
busca
resultou
um
total
104
publicações
dos
quais
2
atenderam
aos
critérios
seleção.
datam
2018
2024.
maior
valor
InOrd
foi
alcançado
pelo
periódico
Cell
Metabolism,
enquanto
revista
Probiotics
and
Antimicrobial
Proteins
apresentou
número
citações.
Ambas
revistas
apresentaram
alto
fator
impacto.
Evidências
preliminares
prebióticos
podem
desencadear
efeitos
imunomoduladores
anti-inflamatórios,
condição
geral
pacientes.
indicam
desequilíbrio
da
doença
eficácia
tratamento,
sublinhando
necessidade
investigações
neste
campo.